Lv1
60 积分 2026-03-29 加入
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2天前
已完结
Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers
25天前
已完结
Chronic inflammation in the etiology of disease across the life span
26天前
已完结
Cardiometabolic-kidney indices and machine learning model for predicting all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a longitudinal cohort study
1个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
4个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
4个月前
已完结
The Glucagon‐Like Peptide‐1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis
4个月前
已完结
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
4个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
4个月前
已完结
皖公网安备34019202002308
